| Product Code: ETC7615749 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Pharmacogenetic Testing Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Iraq Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Iraq Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Iraq Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing demand for personalized medicine in Iraq |
4.2.3 Government initiatives to promote precision medicine and genomics research |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in certain regions of Iraq |
4.3.2 High cost associated with pharmacogenetic testing |
4.3.3 Lack of trained professionals to interpret and implement pharmacogenetic testing results |
5 Iraq Pharmacogenetic Testing Market Trends |
6 Iraq Pharmacogenetic Testing Market, By Types |
6.1 Iraq Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Iraq Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Iraq Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Iraq Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Iraq Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Iraq Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Iraq Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Iraq Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Iraq Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Iraq Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Iraq Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Iraq Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Iraq Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Iraq Pharmacogenetic Testing Market Export to Major Countries |
7.2 Iraq Pharmacogenetic Testing Market Imports from Major Countries |
8 Iraq Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in pharmacogenetic testing |
8.2 Adoption rate of pharmacogenetic testing in clinical practice |
8.3 Number of research studies and publications on pharmacogenetic testing in Iraq |
8.4 Patient satisfaction and outcomes improvement after pharmacogenetic testing implementation |
9 Iraq Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Iraq Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Iraq Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Iraq Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Iraq Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here